Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 234

1.

A Complex Case of Cholestasis in a Patient with ABCB4 and ABCB11 Mutations.

Cardoso MF, E Branco JC, Anapaz V, Rodrigues CG, Carvalho R, Horta D, Martins A, Reis J.

GE Port J Gastroenterol. 2018 Jun;25(4):189-194. doi: 10.1159/000484612. Epub 2017 Nov 25.

2.

Biliary transporter gene mutations in severe intrahepatic cholestasis of pregnancy: diagnostic and management implications.

Yeap SP, Harley H, Thompson R, Williamson KD, Bate J, Sethna F, Farrell G, Hague WB.

J Gastroenterol Hepatol. 2018 Jul 10. doi: 10.1111/jgh.14376. [Epub ahead of print]

PMID:
29992621
3.

Spectrum of genomic variations in Indian patients with progressive familial intrahepatic cholestasis.

Sharma A, Poddar U, Agnihotry S, Phadke SR, Yachha SK, Aggarwal R.

BMC Gastroenterol. 2018 Jul 4;18(1):107. doi: 10.1186/s12876-018-0835-6.

4.

Long-term outcome after cholecystocolostomy for progressive familial intrahepatic cholestasis.

Chen L, Xiao H, Ren XH, Li L.

Hepatol Res. 2018 Jun 22. doi: 10.1111/hepr.13222. [Epub ahead of print]

PMID:
29934967
5.

Phenotypic spectrum and diagnostic pitfalls of ABCB4 deficiency depending on age of onset.

Schatz SB, Jüngst C, Keitel-Anselmo V, Kubitz R, Becker C, Gerner P, Pfister ED, Goldschmidt I, Junge N, Wenning D, Gehring S, Arens S, Bretschneider D, Grothues D, Engelmann G, Lammert F, Baumann U.

Hepatol Commun. 2018 Mar 22;2(5):504-514. doi: 10.1002/hep4.1149. eCollection 2018 May.

6.

Pathologic Features of Hereditary Cholestatic Diseases.

Clouston AD.

Surg Pathol Clin. 2018 Jun;11(2):313-327. doi: 10.1016/j.path.2018.02.001. Epub 2018 Mar 26. Review.

PMID:
29751877
7.

Lysyl oxidase-like protein 2 (LOXL2) modulates barrier function in cholangiocytes in cholestasis.

Pollheimer MJ, Racedo S, Mikels-Vigdal A, Marshall D, Bowlus C, Lackner C, Madl T, Karlsen TH, Hov JR, Lyman SK, Adamkewicz J, Smith V, Moreau E, Zollner G, Eide TJ, Stojakovic T, Scharnagl H, Gruber HJ, Stauber RE, Trauner M, Fickert P.

J Hepatol. 2018 Apr 28. pii: S0168-8278(18)32017-8. doi: 10.1016/j.jhep.2018.04.009. [Epub ahead of print]

PMID:
29709678
8.

Na+ -taurocholate cotransporting polypeptide inhibition has hepatoprotective effects in cholestasis in mice.

Slijepcevic D, Roscam Abbing RLP, Fuchs CD, Haazen LCM, Beuers U, Trauner M, Oude Elferink RPJ, van de Graaf SFJ.

Hepatology. 2018 Mar 24. doi: 10.1002/hep.29888. [Epub ahead of print]

PMID:
29572910
9.

Alterations in Intestinal Microbiota Lead to Production of Interleukin 17 by Intrahepatic γδ T-Cell Receptor-Positive Cells and Pathogenesis of Cholestatic Liver Disease.

Tedesco D, Thapa M, Chin CY, Ge Y, Gong M, Li J, Gumber S, Speck P, Elrod EJ, Burd EM, Kitchens WH, Magliocca JF, Adams AB, Weiss DS, Mohamadzadeh M, Grakoui A.

Gastroenterology. 2018 Jun;154(8):2178-2193. doi: 10.1053/j.gastro.2018.02.019. Epub 2018 Feb 15.

PMID:
29454797
10.

Liver transplantation for decompensated liver cirrhosis caused by progressive familial intrahepatic cholestasis type 3: A case report.

Xiang D, He J, Wang H, Xiong F, Cheng H, Ai J, Shan R, Wan R, Zhang L, Shi J.

Medicine (Baltimore). 2017 Dec;96(50):e9158. doi: 10.1097/MD.0000000000009158.

11.

Cenicriviroc, a cytokine receptor antagonist, potentiates all-trans retinoic acid in reducing liver injury in cholestatic rodents.

Yu D, Cai SY, Mennone A, Vig P, Boyer JL.

Liver Int. 2018 Jun;38(6):1128-1138. doi: 10.1111/liv.13698. Epub 2018 Feb 13.

12.

Unexplained cholestasis in adults and adolescents: diagnostic benefit of genetic examination.

Aamann L, Ørntoft N, Vogel I, Grønbaek H, Becher N, Vilstrup H, Ott P, Lildballe DL.

Scand J Gastroenterol. 2018 Mar;53(3):305-311. doi: 10.1080/00365521.2017.1422800. Epub 2018 Jan 5.

PMID:
29304564
13.

Cryptogenic cholestasis in young and adults: ATP8B1, ABCB11, ABCB4, and TJP2 gene variants analysis by high-throughput sequencing.

Vitale G, Gitto S, Raimondi F, Mattiaccio A, Mantovani V, Vukotic R, D'Errico A, Seri M, Russell RB, Andreone P.

J Gastroenterol. 2018 Aug;53(8):945-958. doi: 10.1007/s00535-017-1423-1. Epub 2017 Dec 13.

PMID:
29238877
14.

An expanded role for heterozygous mutations of ABCB4, ABCB11, ATP8B1, ABCC2 and TJP2 in intrahepatic cholestasis of pregnancy.

Dixon PH, Sambrotta M, Chambers J, Taylor-Harris P, Syngelaki A, Nicolaides K, Knisely AS, Thompson RJ, Williamson C.

Sci Rep. 2017 Sep 18;7(1):11823. doi: 10.1038/s41598-017-11626-x.

15.

Hepatitis B virus surface proteins accelerate cholestatic injury and tumor progression in Abcb4-knockout mice.

Zahner D, Glimm H, Matono T, Churin Y, Herebian D, Mayatepek E, Köhler K, Gattenlöhner S, Stinn A, Tschuschner A, Roderfeld M, Roeb E.

Oncotarget. 2017 Feb 2;8(32):52560-52570. doi: 10.18632/oncotarget.15003. eCollection 2017 Aug 8.

16.

Genetic determinants of cholangiopathies: Molecular and systems genetics.

Reichert MC, Hall RA, Krawczyk M, Lammert F.

Biochim Biophys Acta. 2018 Apr;1864(4 Pt B):1484-1490. doi: 10.1016/j.bbadis.2017.07.029. Epub 2017 Jul 27. Review.

PMID:
28757171
17.

Sequencing of FIC1, BSEP and MDR3 in a large cohort of patients with cholestasis revealed a high number of different genetic variants.

Dröge C, Bonus M, Baumann U, Klindt C, Lainka E, Kathemann S, Brinkert F, Grabhorn E, Pfister ED, Wenning D, Fichtner A, Gotthardt DN, Weiss KH, McKiernan P, Puri RD, Verma IC, Kluge S, Gohlke H, Schmitt L, Kubitz R, Häussinger D, Keitel V.

J Hepatol. 2017 Dec;67(6):1253-1264. doi: 10.1016/j.jhep.2017.07.004. Epub 2017 Jul 19.

PMID:
28733223
18.

Comparison of in silico prediction and experimental assessment of ABCB4 variants identified in patients with biliary diseases.

Khabou B, Durand-Schneider AM, Delaunay JL, Aït-Slimane T, Barbu V, Fakhfakh F, Housset C, Maurice M.

Int J Biochem Cell Biol. 2017 Aug;89:101-109. doi: 10.1016/j.biocel.2017.05.028. Epub 2017 Jun 3.

PMID:
28587926
19.

8-Methoxypsoralen disrupts MDR3-mediated phospholipids efflux and bile acid homeostasis and its relevance to hepatotoxicity.

Zhao G, Xu D, Yuan Z, Jiang Z, Zhou W, Li Z, Yin M, Zhou Z, Zhang L, Wang T.

Toxicology. 2017 Jul 1;386:40-48. doi: 10.1016/j.tox.2017.05.011. Epub 2017 May 24.

PMID:
28552422
20.

Progressive Familial Intrahepatic Cholestasis Type 2 in an Indian Child.

Shah I, Chilkar S.

J Pediatr Genet. 2017 Jun;6(2):126-127. doi: 10.1055/s-0036-1597912. Epub 2017 Jan 2.

Supplemental Content

Loading ...
Support Center